These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2084499)

  • 1. The effects of shear rate on the enzymatic activity of the tissue factor-factor VIIa complex.
    Gemmell CH; Nemerson Y; Turitto V
    Microvasc Res; 1990 Nov; 40(3):327-40. PubMed ID: 2084499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
    Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
    Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.
    Hathcock JJ; Rusinova E; Andree H; Nemerson Y
    Blood Cells Mol Dis; 2006; 36(2):194-8. PubMed ID: 16529959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-bound factor Xa regulates tissue factor activity.
    Hathcock J; Rusinova E; Vaananen H; Nemerson Y
    Biochemistry; 2007 May; 46(20):6134-40. PubMed ID: 17469850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tissue factor-factor VIIa-catalyzed factor X activation by factor Xa-tissue factor pathway inhibitor. A rotating disc study on the effect of phospholipid membrane composition.
    Salemink I; Franssen J; Willems GM; Hemker HC; Lindhout T
    J Biol Chem; 1999 Oct; 274(40):28225-32. PubMed ID: 10497177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A numerical analysis of factor X activation in the presence of tissue factor--factor VIIa complex in a flow reactor.
    Gir S; Slack SM; Turitto VT
    Ann Biomed Eng; 1996; 24(3):394-9. PubMed ID: 8734060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor.
    Repke D; Gemmell CH; Guha A; Turitto VT; Broze GJ; Nemerson Y
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7623-7. PubMed ID: 2120704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting the interaction of tissue factor/factor VII with factor X in a heterogeneous tubular reactor.
    Gemmell CH; Turitto VT; Nemerson Y
    Thromb Haemost; 1991 Feb; 65(2):139-43. PubMed ID: 2053099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of a continuous flow reactor to study the lipoprotein-associated coagulation inhibitor (LACI) that inhibits tissue factor.
    Gemmell CH; Broze GJ; Turitto VT; Nemerson Y
    Blood; 1990 Dec; 76(11):2266-71. PubMed ID: 2257300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow as a regulator of the activation of factor X by tissue factor.
    Gemmell CH; Turitto VT; Nemerson Y
    Blood; 1988 Oct; 72(4):1404-6. PubMed ID: 3262388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow dependence of factor X activation by tissue factor-factor VIIa.
    Contino PB; Andree HA; Nemerson Y
    J Physiol Pharmacol; 1994 Mar; 45(1):81-90. PubMed ID: 8043911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A computational analysis of FXa generation by TF:FVIIa on the surface of rat vascular smooth muscle cells.
    Hall CL; Slack SM; Turitto VT
    Ann Biomed Eng; 1998; 26(1):28-36. PubMed ID: 10355548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation.
    Furukawa S; Nogami K; Ogiwara K; Shima M
    Int J Hematol; 2019 Apr; 109(4):390-401. PubMed ID: 30756344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport rate limited catalysis on macroscopic surfaces: the activation of factor X in a continuous flow enzyme reactor.
    Andree HA; Contino PB; Repke D; Gentry R; Nemerson Y
    Biochemistry; 1994 Apr; 33(14):4368-74. PubMed ID: 8155655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
    Rao LV; Ruf W
    Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV; Petrovan RJ; Ruf W; Olson AJ
    Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
    Camerer E; Huang W; Coughlin SR
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus type 1-encoded glycoprotein C enhances coagulation factor VIIa activity on the virus.
    Sutherland MR; Friedman HM; Pryzdial EL
    Thromb Haemost; 2004 Nov; 92(5):947-55. PubMed ID: 15543320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa.
    Ollivier V; Chabbat J; Herbert JM; Hakim J; de Prost D
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1374-81. PubMed ID: 10807756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of human factor VIIa with tissue factor.
    Krishnaswamy S
    J Biol Chem; 1992 Nov; 267(33):23696-706. PubMed ID: 1429710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.